Korean Co Nuga Medicals Enters
Indian Market
The Korean medical and health
equipments manufacturer and medical service provider, Nuga Medicals Co. Ltd.,
has entered into Indian market with an exclusive collaboration with a Mumbai
based company named Nuga Best Therapy (Maharashtra) Pvt. Ltd.
According to Sandip Desai, Chief
Operating Officer (CEO) Nuga Best Therapy Ltd. Nuga Medicals will introduce in
India its product Nuga Best NM - 5000, claimed to be a combination of the
ancient Estern healing arts of acupressure, massage, Warm Heat, modern
chiropractic theory, far-infrared light therapy, Low Frequency Waves, and modern
technology.
(Ref : Chronicle Pharmabiz
Dated May 18, 2006)
Health Ministry To Lay Down
Quality Standards For Medical Devices Soon
A national level study,
commissioned by the Union Ministry of Health and Family Welfare has highlighted
the importance of comprehensive regulation of medical devices. The study called
for the preparation of an inventory of products and product groups of various
medical devices and equipment that are available in the market.
The report considered the
regulation of medical devices as an excellent opportunity for the Central Drugs
Standard Control Organisation (CDSCO) to generate some revenue from the
licensing of these products, apart from ensuring safe and quality healthcare for
the general population. Noting the absence of a comprehensive set of central
regulations governing the import or manufacture of medical devices, it wanted
CDSCO would be to make an inventory of medical devices that are currently
available in the country.
Certain medical equipment like
X-ray machines, CT Scan etc is regulated by Atomic Energy Regulatory Board.
Barring these, manufacture and marketing of most of the medical devices and
equipment used in the country remain largely unregulated. A recent notification
issued by the Health Ministry had included only certain categories of medical
devices under the 'drug' list which mandates prior marketing approval from CDSCO.
Undertaking the importance of
proper regulatory intervention, the report called for the preparation of a
detailed document of quality standards for every medical device that finds place
in the inventory. Regulating import of devices through import licensing
registration etc., certification of testing laboratories for quality control,
pre-market certification, surveillance and notification, enforcement and post
marketing follow up (leading to even recall of products) have to be undertaken,
the report suggested.
The study, carried out by A F
Ferguson & Co., is yet to be approved by the Health Ministry. The task before
the agency was to study on the options for financial sustainability of drug
regulatory agencies. The study has been funded through the World Bank assisted
Capacity Building Programme.
(Ref : Chronicle Pharmabiz
Dated April 27, 2006)
|